Türkay Toklu

Pre-therapeutic dosimetry of normal organs and tissues of 177Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer

Levent Kabasakal, Mohammad Abuqbeitah, Aslan Aygün et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 206 citations

Normal Organs, Urology, Oncology +8

Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry

Levent Kabasakal, Türkay Toklu, Nami Yeyin et al. · Molecular Imaging and Radionuclide Therapy · 2017 · 79 citations · Full text

Patient doses and dosimetric evaluations in interventional cardiology

Doğan Bor, Turan Olğar, Türkay Toklu et al. · Physica Medica · 2008 · 61 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Coronary Unit +6

177Lu-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours

Emre Demirci, Levent Kabasakal, Türkay Toklu et al. · Nuclear Medicine Communications · 2018 · 61 citations

Assessment of radiation doses to cardiologists during interventional examinations

D. Bor, Turan Olğar, E Onal et al. · Medical Physics · 2009 · 31 citations